{"id":"https://openalex.org/W2951754364","doi":"https://doi.org/10.1248/cpb.53.1062","title":"Biological Evaluation of 2-Aryl-2-fluoropropionic Acids as Possible Platforms for New Medicinal Agents","display_name":"Biological Evaluation of 2-Aryl-2-fluoropropionic Acids as Possible Platforms for New Medicinal Agents","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2951754364","doi":"https://doi.org/10.1248/cpb.53.1062","mag":"2951754364","pmid":"https://pubmed.ncbi.nlm.nih.gov/16079551"},"language":"en","primary_location":{"id":"doi:10.1248/cpb.53.1062","doi":"https://doi.org/10.1248/cpb.53.1062","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.53.1062","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/53/8/53_8_1062/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/cpb/53/8/53_8_1062/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110115970","display_name":"Yoshio Tak\u00e9uchi","orcid":"https://orcid.org/0009-0005-7009-5628","observed_orcids":["https://orcid.org/0009-0005-7009-5628"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshio Takeuchi","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065615959","display_name":"Hidehito Fujisawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidehito Fujisawa","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014176301","display_name":"Tomoya Fujiwara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoya Fujiwara","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114006703","display_name":"Mamoru Matsuura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mamoru Matsuura","raw_affiliation_strings":["Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072325590","display_name":"Hirotsugu Komatsu","orcid":"https://orcid.org/0000-0002-4206-2416","observed_orcids":["https://orcid.org/0000-0002-4206-2416"]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirotsugu Komatsu","raw_affiliation_strings":["Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072701802","display_name":"Satoshi Ueno","orcid":"https://orcid.org/0000-0002-7048-0703","observed_orcids":["https://orcid.org/0000-0002-7048-0703"]},"institutions":[{"id":"https://openalex.org/I4210153337","display_name":"Yakult Central Institute","ror":"https://ror.org/04gcc2383","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210153337"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Ueno","raw_affiliation_strings":["Yakult Central Institute for Microbiological Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yakult Central Institute for Microbiological Research","institution_ids":["https://openalex.org/I4210153337"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110014330","display_name":"Takeshi Matsuzaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153337","display_name":"Yakult Central Institute","ror":"https://ror.org/04gcc2383","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210153337"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeshi Matsuzaki","raw_affiliation_strings":["Yakult Central Institute for Microbiological Research"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yakult Central Institute for Microbiological Research","institution_ids":["https://openalex.org/I4210153337"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7649,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.7447407,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"53","issue":"8","first_page":"1062","last_page":"1064"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.7631999850273132,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.7631999850273132,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.1656000018119812,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10947","display_name":"Fluorine in Organic Chemistry","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluorinated-compounds","display_name":"fluorinated compounds","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibition","display_name":"cyclooxygenase inhibition","score":0.972000002861023},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.925000011920929},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9330000281333923},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.8069999814033508},{"id":"https://openalex.org/keywords/stereochemistry","display_name":"stereochemistry","score":0.6140000224113464},{"id":"https://openalex.org/keywords/cox-1-cox-2-selectivity","display_name":"COX-1/COX-2 selectivity","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9291197657585144},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.7447952032089233},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.5799810886383057},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.5787702202796936},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.5785986185073853},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.5533984899520874},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5037528872489929},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25832730531692505},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2298632562160492},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.21806371212005615},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.19022610783576965},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.05197018384933472},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/cpb.53.1062","doi":"https://doi.org/10.1248/cpb.53.1062","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.53.1062","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/53/8/53_8_1062/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:16079551","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16079551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/cpb.53.1062","doi":"https://doi.org/10.1248/cpb.53.1062","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.53.1062","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/53/8/53_8_1062/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.49000000953674316,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2951754364.pdf","grobid_xml":"https://content.openalex.org/works/W2951754364.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1502025781","https://openalex.org/W1967985001","https://openalex.org/W1985405900","https://openalex.org/W2016729644","https://openalex.org/W2035944680","https://openalex.org/W2037757244","https://openalex.org/W2068122468","https://openalex.org/W2078583586","https://openalex.org/W2082406942","https://openalex.org/W2098675560","https://openalex.org/W2115203110","https://openalex.org/W2485071058","https://openalex.org/W2949648336","https://openalex.org/W4254329876"],"related_works":["https://openalex.org/W2090727056","https://openalex.org/W2315531014","https://openalex.org/W4231897887","https://openalex.org/W2086509974","https://openalex.org/W2597092979","https://openalex.org/W4236819622","https://openalex.org/W2337197069","https://openalex.org/W2951355420","https://openalex.org/W2039718172","https://openalex.org/W2134196108"],"abstract_inverted_index":{"We":[0],"investigated":[1],"the":[2,23,38,52],"cyclooxygenase":[3],"(COX)":[4],"inhibitory":[5,18,30],"and":[6,43,56],"anticancer":[7,47],"activities":[8,53],"of":[9,37,40,51],"2-aryl-2-fluoropropionic":[10],"acids":[11],"1a-e.":[12],"These":[13],"fluorinated":[14],"compounds":[15,26],"showed":[16,45],"lower":[17],"activity":[19,31],"toward":[20],"COX-1":[21],"than":[22],"corresponding":[24],"non-fluorinated":[25],"2a-e":[27],"with":[28],"retained":[29],"against":[32],"COX-2":[33],"resulting":[34],"in":[35,60],"modification":[36],"balance":[39],"COX-1/COX-2":[41],"inhibitions,":[42],"they":[44],"little":[46],"activity.":[48],"Interesting":[49],"differences":[50],"between":[54],"(S)-":[55],"(R)-enantiomers":[57],"were":[58],"observed":[59],"some":[61],"cases.":[62]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2025-10-10T00:00:00"}